Hoda Abdel Hamid
Pediatrics · Pittsburgh, PANPI 1376582304
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $67,776 of the $100,699 with a category attached, or 67.3%. Sarepta Therapeutics, Inc. accounts for 67.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $31,906 and has fallen 98.0% since, to $649 in 2025. Among pediatrics clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $977.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$68K
- Genentech, Inc.$13K
- Pfizer$8K
- Catalyst Pharmaceuticals, Inc.$7K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$2K
- NS Pharma, Inc.$1K
- plus $1K from 5 others
Across 306 payments — averaging $8873.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$1.9M
- Pfizer$355K
- NS Pharma, Inc.$165K
- PTC Therapeutics, Inc.$156K
- Novartis$62K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$48K
What the payments were for
- Consulting fees$67,77667%
- Speaking & faculty fees$11,33011%
- Travel & lodging$17,03917%
- Food & beverage$4,3044%
- Education$2500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 68 | $67,641 |
| Genentech, Inc. | 6 | $13,117 |
| Pfizer | 8 | $8,080 |
| Catalyst Pharmaceuticals, Inc. | 4 | $7,106 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 3 | $2,347 |
| NS Pharma, Inc. | 1 | $1,326 |
| Biogen | 7 | $631 |
| CSL Behring | 3 | $165 |
| Novartis | 1 | $137 |
| Sanofi | 1 | $108 |
| PTC Therapeutics, Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elevidys$23,891
- AGAMREE$7,106
- EVRYSDI$6,600
- Non-Covered Product$6,517
- Exondys 51$6,135
- ZOLGENSMA$2,484
- VILTEPSO$1,326
- ELREXFIO$379
- SPINRAZA$327
- LUMIZYME$108
How this compares
$100,699 in reported general payments places this provider in the 95th percentile of 1,849 pediatrics providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Deflazacort | 13 | $101,464 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Pittsburgh
- Todd WolynnPittsburgh$275K
- Mark BlatterPittsburgh$238K
- Anne-Marie RickPittsburgh$16K
- Tyler HarrisPittsburgh$9K
- Uta Lichter-KoneckiPittsburgh$6K
- Sarah SpringerPittsburgh$5K
- Steven TwanPittsburgh$4K
- H BreckPittsburgh$4K
- Jennifer PreissPittsburgh$4K
- Craig CollisonSpring Mills$670K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.